We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Genetic Assay for Iris Color

By HospiMedica staff writers
Posted on 14 Apr 2005
A new genetic assay is for the inference of iris color from DNA. More...
Along with tests for the inference of continental and ethno-geographic ancestry, the assay allows law enforcement workers to "paint” physical profiles from crime-scene DNA specimens and thereby to augment or substitute for unavailable or incomplete human eye-witness testimony.

Called Retinome, the assay measures multiple genetic variants, or single nucleotide polymorphisms (SNPs), located in regions of the human genome that are involved in pigment production. The test is the first commercially available complex genetics test to be developed from the knowledge provided by the human genome sequencing project. Previously, complex genetic tests were notoriously difficult to develop, in part because their determination is the byproduct of multiple, interacting genes and their expression is usually quantitative rather than discrete (i.e., black/white).

Retinome was developed by DNAPrint genomics (Sarasota, FL, USA). The company collaborated with Victoria University (Melbourne, Australia) and the Victoria Forensic Science Services Center (VFSC) on the project to win a competitive 2004 Australian International Science Linkages (ISL) grant, announced in February 2005. The grant was authored by Dr. Swati Baindur-Hudson, of Victoria University, with the assistance of DNAPrint scientists to support the validation and the potential integration of Retinome at the VFSC.

DNAPrint uses proprietary human genome research methods to develop genomic-based services and products for consumer and forensic markets. The company is also working on a disease-gene discovery program.




Related Links:
DNAPrint

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.